ID

14516

Descrizione

p38 Mitogen−Activated Protein Kinase (MAPK) and Steroid Insensitivity in Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00676572

collegamento

https://clinicaltrials.gov/show/NCT00676572

Keywords

versioni (1)
  1. 19/04/16 19/04/16 -
Titolare del copyright

CC BY-NC 3.0

Caricato su

19 aprile 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Asthma NCT00676572

Inglese

Eligibility Asthma NCT00676572

1 moduli  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00676572
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 18-60
Descrizione

age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
physician diagnosis of asthma
Descrizione

asthma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004096
non-severe asthmatic subjects:
Descrizione

asthma non-severe

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004096
mild to moderately severe asthma.
Descrizione

mild to moderately severe asthma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004096
the groups will be defined as follows, according to their need for treatments (as established in the asthma management gina or bts guidelines):
Descrizione

asthma treatment groups

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C0040808
1. mild: intermittent symptoms and need for reliever bronchodilator less than once a day
Descrizione

mild intermittent asthma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1960045
UMLS CUI [2]
C0006280
2. moderate asthma: well-controlled asthma with minimal symptoms while on inhaled corticosteroid therapy not exceeding 2,000 μg beclomethasone equivalent.
Descrizione

moderate asthma with inhaled steroids

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1960047
UMLS CUI [2]
C0586793
severe asthmatic subjects:
Descrizione

severe asthma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0581126
will have at least 1 major and 2 minor criteria (as below) major characteristics (at least one of the following criteria)
Descrizione

asthma criteria

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0242801
treatment with continuous or near continuous (>50% of year) oral corticosteroids
Descrizione

oral corticosteroids

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0442027
requirement for treatment with high dose inhaled corticosteroids (ics) minor characteristics (at least 2 out of the following)
Descrizione

high dose inhaled corticosteroids

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2065041
UMLS CUI [1,2]
C0444956
1. requirement for daily treatment with a controller medication in addition to ics e.g. laba, theophylline, leukotriene antagonist
Descrizione

requirement for daily controller medication

Tipo di dati

boolean

2. asthma symptoms requiring saba on a daily or near daily basis
Descrizione

short-acting beta-2 agonist

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1373132
3. persistent airways obstruction (fev1 <80% predicted, diurnal pef variation >20%)
Descrizione

fev1, pef variability

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0748133
UMLS CUI [2,1]
C0030735
UMLS CUI [2,2]
C2827666
4. one or more emergency care visits for asthma per year
Descrizione

emergency care visits for asthma

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0583237
UMLS CUI [1,2]
C0004096
5. 3 or more steroid "bursts" per year
Descrizione

steroid burst

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0744425
6. prompt deterioration with ≤ 25% reduction in oral or ics
Descrizione

deterioration with reduction in oral or ics

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0868945
UMLS CUI [2,1]
C0441610
UMLS CUI [2,2]
C0149783
7. near fatal asthma event in the past
Descrizione

near fatal asthma event

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C2826244
UMLS CUI [1,3]
C1302234
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
current smokers, or less than 3 years since quitting smoking (< 5 pack/years)
Descrizione

smoking history

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1519384
UMLS CUI [2]
C1277691
less than 4 weeks from an exacerbation
Descrizione

asthma exacerbation

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0349790
UMLS CUI [1,2]
C0040223
on steroid-sparing agent or immunosuppressant such as azathioprine, methotrexate and ciclosporin
Descrizione

steroid-sparing agent or immunosuppressant

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021081
concomitant anti-ige therapy
Descrizione

anti-ige therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0051978
on anti-platelet or anti-coagulant drugs
Descrizione

anti-platelet or anti-coagulant drugs

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0085826
UMLS CUI [2]
C0003280
low platelet count
Descrizione

platelet count

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032181
pregnancy or breast-feeding
Descrizione

pregnancy or breast-feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
intubation for asthma within 6 months of entry into this study (if undergoing bronchoscopy)
Descrizione

intubation for asthma

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0021925
UMLS CUI [1,2]
C0004096
Ritorna all'inizio della pagina

Similar models

Eligibility Asthma NCT00676572

1 moduli
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00676572
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
age 18-60
boolean
C0001779 (UMLS CUI [1])
asthma
Item
physician diagnosis of asthma
boolean
C0004096 (UMLS CUI [1])
asthma non-severe
Item
non-severe asthmatic subjects:
boolean
C0004096 (UMLS CUI [1])
mild to moderately severe asthma
Item
mild to moderately severe asthma.
boolean
C0004096 (UMLS CUI [1])
asthma treatment groups
Item
the groups will be defined as follows, according to their need for treatments (as established in the asthma management gina or bts guidelines):
boolean
C0004096 (UMLS CUI [1,1])
C0040808 (UMLS CUI [1,2])
mild intermittent asthma
Item
1. mild: intermittent symptoms and need for reliever bronchodilator less than once a day
boolean
C1960045 (UMLS CUI [1])
C0006280 (UMLS CUI [2])
moderate asthma with inhaled steroids
Item
2. moderate asthma: well-controlled asthma with minimal symptoms while on inhaled corticosteroid therapy not exceeding 2,000 μg beclomethasone equivalent.
boolean
C1960047 (UMLS CUI [1])
C0586793 (UMLS CUI [2])
severe asthma
Item
severe asthmatic subjects:
boolean
C0581126 (UMLS CUI [1])
asthma criteria
Item
will have at least 1 major and 2 minor criteria (as below) major characteristics (at least one of the following criteria)
boolean
C0242801 (UMLS CUI [1])
oral corticosteroids
Item
treatment with continuous or near continuous (>50% of year) oral corticosteroids
boolean
C0001617 (UMLS CUI [1,1])
C0442027 (UMLS CUI [1,2])
high dose inhaled corticosteroids
Item
requirement for treatment with high dose inhaled corticosteroids (ics) minor characteristics (at least 2 out of the following)
boolean
C2065041 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
requirement for daily controller medication
Item
1. requirement for daily treatment with a controller medication in addition to ics e.g. laba, theophylline, leukotriene antagonist
boolean
short-acting beta-2 agonist
Item
2. asthma symptoms requiring saba on a daily or near daily basis
boolean
C1373132 (UMLS CUI [1])
fev1, pef variability
Item
3. persistent airways obstruction (fev1 <80% predicted, diurnal pef variation >20%)
boolean
C0748133 (UMLS CUI [1])
C0030735 (UMLS CUI [2,1])
C2827666 (UMLS CUI [2,2])
emergency care visits for asthma
Item
4. one or more emergency care visits for asthma per year
boolean
C0583237 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
steroid burst
Item
5. 3 or more steroid "bursts" per year
boolean
C0744425 (UMLS CUI [1])
deterioration with reduction in oral or ics
Item
6. prompt deterioration with ≤ 25% reduction in oral or ics
boolean
C0868945 (UMLS CUI [1])
C0441610 (UMLS CUI [2,1])
C0149783 (UMLS CUI [2,2])
near fatal asthma event
Item
7. near fatal asthma event in the past
boolean
C0004096 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C1302234 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
smoking history
Item
current smokers, or less than 3 years since quitting smoking (< 5 pack/years)
boolean
C1519384 (UMLS CUI [1])
C1277691 (UMLS CUI [2])
asthma exacerbation
Item
less than 4 weeks from an exacerbation
boolean
C0349790 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
steroid-sparing agent or immunosuppressant
Item
on steroid-sparing agent or immunosuppressant such as azathioprine, methotrexate and ciclosporin
boolean
C0021081 (UMLS CUI [1])
anti-ige therapy
Item
concomitant anti-ige therapy
boolean
C0051978 (UMLS CUI [1])
anti-platelet or anti-coagulant drugs
Item
on anti-platelet or anti-coagulant drugs
boolean
C0085826 (UMLS CUI [1])
C0003280 (UMLS CUI [2])
platelet count
Item
low platelet count
boolean
C0032181 (UMLS CUI [1])
pregnancy or breast-feeding
Item
pregnancy or breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
intubation for asthma
Item
intubation for asthma within 6 months of entry into this study (if undergoing bronchoscopy)
boolean
C0021925 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial